Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome

Abstract

Both our experience and the literature suggest ambiguous effects of bevacizumab; inhibition of VEGF alone may be insufficient because multiple cytokines are upregulated, or aberrant neo-vascularization may have already fully developed in the advanced stage of POEMS syndrome.